FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter (OTC) nasal decongestants, citing concerns over its effectiveness. After reviewing available data,
Hosted on MSN9h
FDA Proposes Pulling Ineffective Decongestant From MarketAn FDA advisory committee has unanimously concluded that oral phenylephrine, a decongestant found in many cold and flu ...
The U.S. Food and Drug Administration (FDA) recently held a Patient Engagement Advisory Committee meeting focused on clinical trial informed ...
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
A New York federal judge on Tuesday dismissed about 100 lawsuits that claimed Procter & Gamble , Haleon and other companies ...
said during the advisory committee meeting in September. "Design a real study, do a real study, then we can talk about the ...
The U.S. Food and Drug Administration's ("FDA") new advisory committee on digital health is set to examine its approach for evaluating and ...
On Halloween, Lexicon was haunted again as an FDA advisory committee voted 11-3 to reject Zynquista as an accompanying ...
FDA officials said an agency review of the available data found oral phenylephrine is not effective as a nasal decongestant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback